Webster Bank, N. A. Crispr Therapeutics Ag Transaction History

Webster Bank, N. A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$60.67 - $89.12 $14,014 - $20,586	-231 Reduced 62.26%	140 $9,000
Q2 2023 Jul 13, 2023	SELL	$43.47 - $67.77 $12,388 - $19,314	-285 Reduced 43.45%	371 $20,000
Q4 2021 Jan 12, 2022	BUY	$70.09 - $111.29 $29,788 - $47,298	425 Added 183.98%	656 $50,000
Q4 2020 Jan 07, 2021	SELL	$79.67 - $173.23 $7,090 - $15,417	-89 Reduced 27.81%	231 $35,000
Q3 2020 Oct 22, 2020	BUY	$78.5 - $100.64 $25,120 - $32,204	320 New	320 $27,000
Q2 2020 Jul 09, 2020	SELL	$38.5 - $76.05 $16,170 - $31,941	-420 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$36.68 - $73.13 $15,405 - $30,714	420 New	420 $26,000

486

57.9M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.39B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Webster Bank, N. A., based on Form 13F filings with the SEC.

Stay updated on Webster Bank, N. A. with notifications on news.